Coca-Cola — $KO
A defensive compounder — research note. Spot ≈ $83.
The thesis
KO is engineered as a margin and capital-return story, not a volume-growth story — a low-volatility, all-weather staple that compounds steadily. The setup is "dependable" rather than "explosive."
Income statement
Revenue modeled to grow $49B → $52.47B (2026–28, ~3.5% CAGR) with EPS $3.27 → $3.71 (~6.5% CAGR) — earnings outgrowing the top line as margins expand. Gross margin improves 59.5% → 61.7% and net margin 23.4% → 27.9%. At ~24x our 2027E EPS (PEG ~3.7), the stock is priced as a defensive dividend name, not a growth story — fitting a low-single-digit top line driven by pricing, mix, procurement, and productivity in an asset-light model.
| Gross margin | ~61.7% |
| Net margin | ~27.9% |
| Rev CAGR (26–28) | ~3.5% |
| EPS CAGR (26–28) | ~6.5% |
Margins are expanding and earnings are outgrowing the top line — a pricing, mix, and productivity story, not a volume one.
Balance sheet
Solid for a mature staple: assets $98B → $104B, equity $26B → $34B as retained earnings outpace buybacks (tangible book flipped positive), total debt roughly flat at $42–44B — conservatively managed. The real story is the ~$11B cash position acting as dry powder against the IRS dispute — an unfavorable outcome could be absorbed without new borrowing.
| Net leverage | ~1.6× |
| Debt / equity | ~1.3× |
| Cash on hand | ~$11B |
Conservatively levered with a large cash cushion — enough dry powder to absorb an adverse IRS ruling without new borrowing.
Cash flow
The standout. Reported operating cash optically fell ($11.6B → $6.5B → $7.4B, 2023–25), but that's distorted by a $6B IRS litigation deposit (2024) and a $6.1B fairlife contingent payment (2025); strip those and CFO is a steady $13–14B. Capex is flat at ~$2.1B/yr (~4% of sales). FCF, similarly adjusted, runs toward $12B (2026) and $14.6B (2028), with ~$7–8B/yr returned via dividends and modest buybacks. A very strong cash-conversion profile.
| FCF margin | ~24% |
| CapEx / sales | ~4% |
| Dividend payout | ~65% |
Asset-light and highly cash-generative — minimal reinvestment leaves ample room for a well-covered, growing dividend.
Projections
Our own estimates for Coca-Cola's revenue and earnings through 2028.
Revenue projection ($B)
OptionFlowTracker estimates · ~3.5% 2-yr CAGR. 2027 interpolated.
EPS projection ($)
OptionFlowTracker estimates · ~6.5% 2-yr CAGR. 2027 interpolated.
Our valuation
We value KO on a forward earnings multiple. Given its defensive quality, steadily expanding margins, and dependable dividend, KO has historically commanded a premium multiple in the low-to-mid 20s. We apply that to our own 2027 year-end EPS estimate of $3.48 across three scenarios.
| Scenario | Forward P/E | 2027E EPS | Fair value |
|---|---|---|---|
| Bear | 22× | $3.48 | ~$77 |
| Base | 24.5× | $3.48 | ~$85 |
| Bull | 27× | $3.48 | ~$94 |
Our base case of roughly $85 lands in line with current Street targets of about $85–$88 (per J.P. Morgan and Evercore). The setup skews toward steady, dividend-supported compounding rather than explosive upside.
Peer comparison
Against its closest beverage-staple peers, KO stacks up as the quality-premium name. Here's how it compares on valuation, growth, and yield.
| Company | Fwd P/E (2027E) | Est. EPS growth | PEG | Div yield |
|---|---|---|---|---|
| Coca-Cola (KO) | 23.9× | ~6.5% | ~3.7 | 2.6% |
| PepsiCo (PEP) | 16.5× | ~6% | ~2.8 | 4.2% |
| Keurig Dr Pepper (KDP) | 12.1× | ~11% | ~1.1 | 3.1% |
Forward P/E uses 2027 estimated EPS; dividend yields as of June 2026. EPS growth and PEG are our estimates. PEG = forward P/E (2027E) ÷ est. annual EPS growth.
KO carries the richest multiple and the highest PEG of the three — the market pays a premium for its defensiveness, brand strength, and expanding margins. PepsiCo offers a notably higher dividend yield at a cheaper multiple, while Keurig Dr Pepper is the cheapest and fastest-growing. In short, KO is the quality-premium staple; the others screen cheaper on a growth-adjusted basis. That premium is simply the price of owning the most defensive name in the group.
Where the Street sits
Analyst price targets cluster roughly $85–$88 (per J.P. Morgan and Evercore), implying steady rather than dramatic upside from here.
Technical read
More defensive hold than momentum breakout — recently mid-$70s to low-$80s, trading above its 50/150/200-day averages with momentum improving (low-vol name, beta ~0.23, in an out-of-favor sector). Dips have been bought and the trend is higher; nothing flashy, just steady.
Fundamentals said ~$85. This week, the tape agreed.
We only get interested when three lenses line up — the fundamental case, the chart, and the options flow. On KO, they now point the same direction.
Fundamental
Defensive compounder, margins near records, ~$85 fair value.
Technical
Above its 50/150/200-day moving averages, low-vol uptrend (beta ~0.23).
Options Flow
$1.46M in $83 calls lifted above the ask — fresh, aggressive, bullish.
Total premium
$1.46M
Avg fill
$0.99
Position size
14,750
Day volume
15,037
Open interest
362
Delta
0.38
Entered
Jul 1, 2026 · 11:08 AM
Peak return since exec.
N/A
Volume ran ~41× the open interest — a near-dead strike lit up, i.e. a fresh opening position, not an add.
On July 1, one block lifted 14,750 KO July $83 calls above the ask — the buyer paid up, and the size dwarfed the existing open interest. It's a near-term, directional bet. On its own, a single print isn't a thesis; but here it's the flow lens pointing the same way the fundamentals and the chart already were. When the three agree, we pay attention. Research and education, not financial advice.
Insiders
Exercising options and selling into strength — consistent with planned diversification rather than distress, though there's no conviction buying to lean on either.
Key risks
The IRS tax case is the main overhang (a full loss could mean a materially higher tax rate and a one-time liability, though the outcome isn't viewed as fully binary); plus the GLP-1 demand overhang, potential sugar/health regulation, and macro pressure on the away-from-home channel.
Bottom line
KO is a high-quality, defensive compounder — expanding margins, a fortress balance sheet with ~$11B of dry powder, and dependable cash generation funding a well-covered dividend. Our base-case fair value of ~$85 sits in line with the Street ($85–$88), so the stock looks fairly valued rather than cheap — you're paying a premium multiple (the highest PEG in its peer group) for that defensiveness. It fits the role of a low-volatility, income-oriented portfolio stabilizer; the main swing factor remains the IRS tax case. Research and education only — not a recommendation; size and manage risk to your own plan.
Research and education only. Not financial advice, and not a recommendation to buy or sell any security. Company figures reflect OptionFlowTracker's own estimates and analysis; third-party price targets are as publicly reported.